Business Analysis for Diabetic Products

Diabetes has become a matter of huge concern as it is a cosmopolitan disorder with an estimated 285 million diabetic, corresponding to 6.4 percentage of world’s adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 percentage of the adult population. The rate of this disorder is on it’s highest at increase. As it is a leading problem globally there is also a gigantic demand for the diagnosis and screening, medication. The global type 2 diabetes market is set to almost double from $31.2 billion in 2015 to $58.7 billion by 2025, representing a compound annual growth rate of 6.5%, according to research and consulting firm Global Data.

The pharmaceutical business is attaining a top places in this field of medication.   

  • Insulin biosimilars development
  • Novel paradigms

Related Conference of Business Analysis for Diabetic Products

September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France
October 20-21, 2026

32nd World Diabetes & Heart Congress

Amsterdam, Netherlands
October 22-23, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
February 25-26, 2027

20th International Summit on Diabetes

London, UK
March 23-24, 2027

7th Annual Summit on Diabetes and Endocrinology

Paris, France
March 29-30, 2027

8th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Business Analysis for Diabetic Products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in